Literature DB >> 1315049

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

J Abe1, B L Kotzin, K Jujo, M E Melish, M P Glode, T Kohsaka, D Y Leung.   

Abstract

Kawasaki disease (KD) is an acute vasculitis complicated by the development of coronary artery abnormalities. The etiology of KD is unknown. Based on the observation that KD is associated with marked activation of T cells and monocyte/macrophages, we hypothesized that KD may be caused by a superantigen [e.g., a bacterial toxin that stimulates T cells expressing particular T-cell receptor beta chain variable (V beta) gene segments]. Peripheral blood T cells from patients in the acute and convalescent phases of KD and from various control groups were analyzed for T-cell receptor V beta gene expression by using a quantitative PCR technique and cytofluorographic analysis with available anti-V beta monoclonal antibodies. Patients with acute KD demonstrated significantly elevated levels of circulating V beta 2+ and V beta 8.1+ T cells compared to the other control groups. none of the other 20 V beta populations analyzed by quantitative PCR were found to be significantly elevated. Using flow cytometry, we confirmed a significant elevation of T cells reactive with anti-V beta 8.1 and the lack of change in several other V beta subsets--i.e. V beta 5.1, -5.2, -6.7, and -12. During the convalescence phase of KD, there was a reduction in the abnormal levels of V beta 2+ and V beta 8.1+ T cells. These observations suggest that KD may be caused by a superantigen and may provide insight into the nature of the etiologic agent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315049      PMCID: PMC525633          DOI: 10.1073/pnas.89.9.4066

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Immunologic aspects of Kawasaki syndrome.

Authors:  D Y Leung
Journal:  J Rheumatol Suppl       Date:  1990-09

2.  Centers for Disease Control (CDC) case definition for Kawasaki syndrome.

Authors:  A M Rauch; E S Hurwitz
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

Review 3.  Cytokines as communication signals between leukocytes and endothelial cells.

Authors:  A Mantovani; E Dejana
Journal:  Immunol Today       Date:  1989-11

4.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.

Authors:  T Matsubara; S Furukawa; K Yabuta
Journal:  Clin Immunol Immunopathol       Date:  1990-07

5.  Inherited polymorphism of the human T-cell antigen receptor detected by a monoclonal antibody.

Authors:  D N Posnett; C Y Wang; S M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Serum interferon concentrations and retroviral serology in Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman; O T Preble; B J Poiesz; G D Ehrlich; J R Sullivan
Journal:  Pediatr Infect Dis J       Date:  1988-09       Impact factor: 2.129

7.  Spontaneous tumor necrosis factor production in Kawasaki disease.

Authors:  B A Lang; E D Silverman; R M Laxer; A S Lau
Journal:  J Pediatr       Date:  1989-12       Impact factor: 4.406

8.  Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

Authors:  M Terai; Y Kohno; M Namba; T Umemiya; K Niwa; H Nakajima; A Mikata
Journal:  Hum Pathol       Date:  1990-02       Impact factor: 3.466

9.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

10.  Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.

Authors:  D Y Leung; R S Geha; J W Newburger; J C Burns; W Fiers; L A Lapierre; J S Pober
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  91 in total

1.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 2.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 3.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

4.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

5.  Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever.

Authors:  W G Abbott; M A Skinner; L Voss; D Lennon; P L Tan; J D Fraser; I J Simpson; R Ameratunga; A Geursen
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report.

Authors:  Timothy Ronan Leahy; Eyal Cohen; Upton D Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis.

Authors:  R Giscombe; J Grunewald; S Nityanand; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

Authors:  D Y Leung; J B Travers; R Giorno; D A Norris; R Skinner; J Aelion; L V Kazemi; M H Kim; A E Trumble; M Kotb
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD).

Authors:  Y Takata; S Seki; H Dobashi; S Takeshita; K Nakatani; Y Kamezawa; H Hiraide; I Sekine; S Yoshioka
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Moyamoya disease with precocious puberty and pustular psoriasis.

Authors:  K Kazumata; S Kuroda; K Houkin; H Abe; T Kiyohara; H Kobayashi; A Okuno
Journal:  Childs Nerv Syst       Date:  1996-06       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.